These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 553798)

  • 21. [A case regarded as an occult breast cancer treated without mastectomy].
    Kawashima T; Miyazawa Y; Sakata H; Matsubara H; Ryu M; Ochiai T
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):825-8. PubMed ID: 15984524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant androgen treatment of operable breast cancer--a 20 year analysis.
    Karydas I; Fentiman IS; Tong D; Bulbrook RD; Hayward JL
    Eur J Surg Oncol; 1987 Apr; 13(2):113-7. PubMed ID: 3556591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary angiosarcoma of the breast].
    Köhler U; Horn LC; Rosenkranz M; Weidenbach H; Bilek K
    Zentralbl Gynakol; 1996; 118(5):295-8. PubMed ID: 8701627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant tamoxifen in postmenopausal high-risk breast cancer patients: present status of Danish Breast Cancer Cooperative Group trials.
    Mouridsen HT; Andersen AP; Brincker H; Dombernowsky P; Rose C; Andersen KW
    NCI Monogr; 1986; (1):115-8. PubMed ID: 3534583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nodal micrometastases status--will it influence decisions on surgical and adjuvant treatment for breast cancer?
    Harissis H; Fatouros M
    Ann Surg Oncol; 2008 Apr; 15(4):1256-7; author reply 1258. PubMed ID: 18239968
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug concentration in axillary lymph nodes of patients with breast cancer after lymphatic chemotherapy].
    Chen JH; Yang YM; Li KZ; Ling R; Yao Q; Yang H
    Ai Zheng; 2005 Apr; 24(4):494-7. PubMed ID: 15820077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The choice of surgical treatment of operable invasive breast cancer (author's transl)].
    Kraljević L; Maksimović V; Nikolić M; Perković Z
    Lijec Vjesn; 1977 Nov; 99(11):688-90. PubMed ID: 607039
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cooperative study of postoperative long-term adjuvant therapy of breast cancer. First study of a series--comparative study between postoperative tegafur administration and no adjuvant chemotherapy].
    Terasawa T; Kousaki G; Sakai K; Senoo T; Taguchi T; Iwasa Z; Utsunomiya J; Okajima K; Okamoto E; Kawahara T
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2073-80. PubMed ID: 2840035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy for node-negative breast cancer: a proactive view.
    Glick JH
    Important Adv Oncol; 1990; ():183-97. PubMed ID: 2182518
    [No Abstract]   [Full Text] [Related]  

  • 31. More evidence that locoregional radiation therapy improves survival: what should we do?
    Whelan T; Levine M
    J Natl Cancer Inst; 2005 Jan; 97(2):82-4. PubMed ID: 15657332
    [No Abstract]   [Full Text] [Related]  

  • 32. [The problem of the treatment of the operable breast cancer (author's transl)].
    Lantin A; Maskens A; Michel L; Vandeperre J
    Acta Chir Belg; 1977; 76(4):445-52. PubMed ID: 919992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Actual problems concerning the surgical treatment of the female breast-cancer (author's transl)].
    Serý Z; Hiklov-Será D; Gazárek F
    Cesk Gynekol; 1975 Feb; 40(1):35-8. PubMed ID: 1131895
    [No Abstract]   [Full Text] [Related]  

  • 34. [Surgical and plastic reconstructive therapy of breast carcinoma].
    Schrenk P
    Wien Med Wochenschr; 2000; 150(4):63-71. PubMed ID: 10829306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of intramammary nodes in completion mastectomy specimens after axillary node sampling: implications for breast conserving surgery.
    Rampaul RS; Dale OT; Mitchell M; Blamey RW; Macmillan RD; Robertson JF; Ellis IO
    Breast; 2008 Apr; 17(2):195-8. PubMed ID: 18164619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sinus histiocytosis in the lymph nodes of breast cancer patients having undergone extensive radical mastectomy].
    Mizuno S; Funahashi H; Fujimoto M; Sugiura H; Takeuchi M; Satoh Y; Nakanishi N; Fukatsu T; Nakashima N
    Gan No Rinsho; 1985 Aug; 31(10):1253-6. PubMed ID: 4057560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant therapy for node-negative breast cancer: a cautious interpretation.
    Henderson IC
    Important Adv Oncol; 1990; ():199-216. PubMed ID: 1691137
    [No Abstract]   [Full Text] [Related]  

  • 39. [Modified radical mastectomy. Experience of the Institut J. Bordet (author's transl)].
    Mendes da Costa P; Mattheiem W; Andry G
    Acta Chir Belg; 1977; 76(4):423-9. PubMed ID: 919989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.